ERN1 and Other metabolic disease: In contrast, the reduced translocation was significantly recovered in the IBF-R-treated groups (quantified in Figure 3d), suggesting a distinct molecular mechanism against metabolic disorders and obesity than recognized ER stress axis “IRE1α phosphorylation-sXBP-1 activation.